Latest / PETRI DISH PERSPECTIVES
August 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail
Welcome to your essential overview of the global biotech and pharmaceutical landscape for August 2026!
This month was defined by major dealmaking, a resurgence in biotech financing, and growing questions about where the global biotech industry is headed. Roche made a $2.5 billion bet on Hanmi, McKesson acquired Precision Medicine Group for $2.25 billion, and the investors behind Metsera quickly returned with Sentivera and a licensing deal worth up to $1.5 billion. Meanwhile, companies including Apnimed, Attovia, and Braveheart kept the IPO market active, suggesting that…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.